| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $32,752,819 ) (Continued on the next page) |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA256133 | Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy | 000 | 3 | NIH | 6/20/2023 | $706,097 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U24CA248138 | THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE | 002 | 3 | NIH | 9/18/2023 | $366,000 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U24CA248138 | THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE | 001 | 3 | NIH | 4/4/2023 | $839,850 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 001 | 5 | NIH | 3/14/2023 | $2,713,421 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI139749 | CD4 T cell control of cytomegalovirus | 000 | 5 | NIH | 12/21/2022 | $565,653 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 000 | 3 | NIH | 1/27/2023 | $568,385 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 003 | 5 | NIH | 11/2/2022 | $823,202 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI040127 | Signal transduction and gene induction in lymphocytes | 000 | 31 | NIH | 8/3/2023 | $658,800 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37AI125068 | Maximizing germinal centers and somatic hypermutation to HIV Env immunogens | 000 | 8 | NIH | 1/4/2023 | $869,654 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA260588 | SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects | 002 | 2 | NIH | 6/21/2023 | $0 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 000 | 5 | NIH | 11/17/2022 | $470,757 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA260588 | SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects | 000 | 2 | NIH | 6/2/2023 | $1,130,292 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 001 | 5 | NIH | 3/16/2023 | $41,844 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA247500 | Exploring the potential of TET inhibition in cancer immunotherapy | 001 | 4 | NIH | 9/8/2023 | $104,582 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA247500 | Exploring the potential of TET inhibition in cancer immunotherapy | 000 | 4 | NIH | 6/30/2023 | $492,576 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37CA276779 | Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy | 000 | 1 | NIH | 6/23/2023 | $418,613 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM128938 | Studying the function of human genetic variation in the light of 3D genome organization | 000 | 6 | NIH | 6/1/2023 | $721,350 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI178427 | Structure of the SARS-CoV-2 Nucleocapsid: building block to viral capsid | 000 | 1 | NIH | 7/5/2023 | $285,857 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI173927 | Experimental identification of functional GWAS variants linked to COVID-19 severity in immune cells | 000 | 1 | NIH | 5/22/2023 | $228,750 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI150753 | Developing computational models to predict the immune response to B. pertussis booster vaccination | 003 | 4 | NIH | 7/25/2023 | $0 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI128589 | Investigating the role of TET deficiency in promoting T cell expansion and inflammation | 000 | 7 | NIH | 5/16/2023 | $549,000 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI173884 | A novel CD4+ T cell subset associated with allergy protection | 000 | 1 | NIH | 7/11/2023 | $274,500 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI150753 | Developing computational models to predict the immune response to B. pertussis booster vaccination | 000 | 4 | NIH | 2/21/2023 | $1,350,127 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 001 | 7 | NIH | 6/22/2023 | $257,278 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI163665 | Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma | 000 | 2 | NIH | 7/25/2023 | $457,500 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI143934 | The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells | 000 | 4 | NIH | 1/16/2023 | $688,446 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01DK135683 | Genetic studies linking LSP1 function in T cells to Inflammatory Bowel Disease | 000 | 1 | NIH | 3/6/2023 | $402,600 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination | 002 | 9 | NIH | 6/1/2023 | $2,391,540 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI170010 | Dynamic analysis of beta cell attacks in response to virus infection in Human pancreatic slices | 000 | 1 | NIH | 3/27/2023 | $274,500 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM147554 | Elucidating the signaling and protein interaction networks of the O-GlcNAc transferase during embryonic stem cell state transitions | 000 | 2 | NIH | 5/8/2023 | $457,500 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142790 | Consortium for Immunotherapeutics against Emerging Viral Threats | 002 | 5 | NIH | 6/28/2023 | $7,006,270 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R24AI108564 | Research Resources: Epigenomic and Transcriptomic Profile of Human Immune Cells | 000 | 9 | NIH | 7/26/2023 | $1,093,781 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 001 | 2 | NIH | 5/25/2023 | $419,705 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 000 | 2 | NIH | 5/22/2023 | $3,037,897 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI101423 | The role of TRAIL in immune control of cytomegalovirus | 000 | 10 | NIH | 5/4/2023 | $549,000 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 000 | 35 | NIH | 2/15/2023 | $842,353 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI092453 | Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes | 001 | 11 | NIH | 4/10/2023 | $549,000 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI163188 | Development of a Replicon RNA-based Vaccine against Dengue and Zika | 000 | 3 | NIH | 5/4/2023 | $721,849 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 002 | 4 | NIH | 8/25/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 000 | 4 | NIH | 2/16/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U24CA248138 | THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE | 000 | 2 | NIH | 12/16/2022 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA260588 | SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects | 001 | 2 | NIH | 6/21/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 002 | 4 | NIH | 10/18/2022 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01DE028227 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers | 001 | 5 | NIH | 1/3/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01DE028227 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers | 001 | 5 | NIH | 1/3/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI150753 | Developing computational models to predict the immune response to B. pertussis booster vaccination | 002 | 3 | NIH | 7/25/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | F31DK124078 | The Role of Intestinal Epithelial Cells in the Generation of Protective CD4 Cytotoxic T Lymphocytes | 000 | 3 | NIH | 5/15/2023 | -$1,509 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination | 001 | 8 | NIH | 5/31/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination | 000 | 8 | NIH | 10/21/2022 | $0 |
|
